# A Drug-Drug Interaction Study of CTL0801 and CTL0802 Compared to Coadministration in Healthy Adult Volunteers

> **NCT05002244** · PHASE1 · COMPLETED · sponsor: **Celltrion** · enrollment: 37 (actual)

## Conditions studied

- Health, Subjective

## Interventions

- **DRUG:** CTL0801 (Azilsartan)
- **DRUG:** CTL0802 (Rosuvastatin)
- **DRUG:** CTL0801 (Azilsartan) + CTL0802 (Rosuvastatin)

## Key facts

- **NCT ID:** NCT05002244
- **Lead sponsor:** Celltrion
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-07-23
- **Primary completion:** 2021-08-29
- **Final completion:** 2021-09-13
- **Target enrollment:** 37 (ACTUAL)
- **Last updated:** 2021-12-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05002244

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05002244, "A Drug-Drug Interaction Study of CTL0801 and CTL0802 Compared to Coadministration in Healthy Adult Volunteers". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05002244. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*